Clinical Trial Update: Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)

View source ↗

Summary

A clinical trial evaluating SV40 vector-based therapy for chronic myeloid leukemia has completed. The study was sponsored by Hadassah Medical Organization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• SV40 vectors

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Chronic Myeloid Leukemia | Status: COMPLETED